<HTML>
<HEAD>
   <TITLE>phytomedical8k.htm - Generated by SEC Publisher for SEC Filing</TITLE>
</HEAD>

<BODY bgcolor="#ffffff">

<a name="page_1"></a>
<p align=center style='margin:0in;margin-bottom:.0001pt;text-align:center;'><b><font color=black face="Times New Roman,serif" lang=EN-US style='font-size:14.0pt;'>SECURITIES AND EXCHANGE COMMISSION</font></b></p>
<p align=center style='margin:0in;margin-bottom:.0001pt;text-align:center;'><b><font color=black face="Times New Roman,serif" lang=EN-US style='font-size:10.0pt;'>Washington, D.C. &nbsp;20549</font></b></p>
<p style='margin:0in;margin-bottom:.0001pt;'><font face="Times New Roman,serif" lang=EN-US style='font-size:8.0pt;'>&nbsp;</font></p>
<p align=center style='margin:0in;margin-bottom:.0001pt;text-align:center;'><b><font color=black face="Times New Roman,serif" lang=EN-US style='font-size:12.0pt;'>FORM 8-K</font></b></p>
<p style='margin:0in;margin-bottom:.0001pt;'><font face="Times New Roman,serif" lang=EN-US style='font-size:8.0pt;'>&nbsp;</font></p>
<p align=center style='margin:0in;margin-bottom:.0001pt;text-align:center;'><b><font color=black face="Times New Roman,serif" lang=EN-US style='font-size:10.0pt;'>CURRENT REPORT</font></b></p>
<p style='margin:0in;margin-bottom:.0001pt;'><font face="Times New Roman,serif" lang=EN-US style='font-size:8.0pt;'>&nbsp;</font></p>
<p align=center style='margin:0in;margin-bottom:.0001pt;text-align:center;'><font color=black face="Times New Roman,serif" lang=EN-US style='font-size:10.0pt;'>Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</font></p>
<p style='margin:0in;margin-bottom:.0001pt;'><font face="Times New Roman,serif" lang=EN-US style='font-size:8.0pt;'>&nbsp;</font></p>
<p align=center style='margin:0in;margin-bottom:.0001pt;text-align:center;'><b><u><font color=black face="Times New Roman,serif" lang=EN-US style='font-size:11.0pt;'>August 5, 2009</font></u></b></p>
<p align=center style='margin:0in;margin-bottom:.0001pt;text-align:center;'><font color=black face="Times New Roman,serif" lang=EN-US style='font-size:8.0pt;'>Date of Report (Date of earliest event reported)</font></p>
<p style='margin:0in;margin-bottom:.0001pt;'><font face="Times New Roman,serif" lang=EN-US style='font-size:8.0pt;'>&nbsp;</font></p>
<p align=center style='margin:0in;margin-bottom:.0001pt;text-align:center;'><b><u><font color=black face="Times New Roman,serif" lang=EN-US style='font-size:16.0pt;'>PhytoMedical Technologies, Inc.</font></u></b></p>
<p align=center style='margin:0in;margin-bottom:.0001pt;text-align:center;'><font color=black face="Times New Roman,serif" lang=EN-US style='font-size:8.0pt;'>(Exact name of registrant as specified in its charter)</font></p>
<p style='margin:0in;margin-bottom:.0001pt;'><font face="Times New Roman,serif" lang=EN-US style='font-size:8.0pt;'>&nbsp;</font></p>
<p align=center style='margin:0in;margin-bottom:.0001pt;text-align:center;'><b><u><font color=black face="Times New Roman,serif" lang=EN-US style='font-size:10.0pt;'>Nevada</font></u></b></p>
<p align=center style='margin:0in;margin-bottom:.0001pt;text-align:center;'><font color=black face="Times New Roman,serif" lang=EN-US style='font-size:8.0pt;'>(State or other jurisdiction of incorporation)</font></p>
<p style='margin:0in;margin-bottom:.0001pt;'><font face="Times New Roman,serif" lang=EN-US style='font-size:8.0pt;'>&nbsp;</font></p>
<p align=center style='margin:0in;margin-bottom:.0001pt;text-align:center;'><b><u><font color=black face="Times New Roman,serif" lang=EN-US style='font-size:10.0pt;'>000-28790</font></u></b><font color=black face="Times New Roman,serif" lang=EN-US style='font-size:8.0pt;'> </font></p>
<p align=center style='margin:0in;margin-bottom:.0001pt;text-align:center;'><font color=black face="Times New Roman,serif" lang=EN-US style='font-size:8.0pt;'>(Commission File Number)</font></p>
<p style='margin:0in;margin-bottom:.0001pt;'><font face="Times New Roman,serif" lang=EN-US style='font-size:8.0pt;'>&nbsp;</font></p>
<p align=center style='margin:0in;margin-bottom:.0001pt;text-align:center;'><b><u><font color=black face="Times New Roman,serif" lang=EN-US style='font-size:10.0pt;'>87-0429962</font></u></b><font color=black face="Times New Roman,serif" lang=EN-US style='font-size:8.0pt;'> </font></p>
<p align=center style='margin:0in;margin-bottom:.0001pt;text-align:center;'><font color=black face="Times New Roman,serif" lang=EN-US style='font-size:8.0pt;'>(I.R.S. Employer Identification No.)</font></p>
<p align=center style='margin:0in;margin-bottom:.0001pt;text-align:center;'><b><font color=black face="Times New Roman,serif" lang=EN-US style='font-size:10.0pt;'><br>
</font></b><b><u><font color=black face="Times New Roman,serif" lang=EN-US style='font-size:10.0pt;'>100 Overlook Drive, 2nd Floor, Princeton, NJ &nbsp;08540</font></u></b><font color=black face="Times New Roman,serif" lang=EN-US style='font-size:8.0pt;'> </font></p>
<p align=center style='margin:0in;margin-bottom:.0001pt;text-align:center;'><font color=black face="Times New Roman,serif" lang=EN-US style='font-size:8.0pt;'>(Address of principal executive offices)</font></p>
<p style='margin:0in;margin-bottom:.0001pt;'><font face="Times New Roman,serif" lang=EN-US style='font-size:8.0pt;'>&nbsp;</font></p>
<p align=center style='margin:0in;margin-bottom:.0001pt;text-align:center;'><b><u><font color=black face="Times New Roman,serif" lang=EN-US style='font-size:10.0pt;'>(800) 611-3388</font></u></b></p>
<p align=center style='margin:0in;margin-bottom:.0001pt;text-align:center;'><font color=black face="Times New Roman,serif" lang=EN-US style='font-size:8.0pt;'>&nbsp;(Registrant&#8217;s telephone number, including area code)</font></p>
<p style='margin:0in;margin-bottom:.0001pt;'><font face="Times New Roman,serif" lang=EN-US style='font-size:8.0pt;'>&nbsp;</font></p>
<p style='margin:0in;margin-bottom:.0001pt;'><font color=black face="Times New Roman,serif" lang=EN-US style='font-size:10.0pt;'>Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):</font></p>
<p style='margin:0in;margin-bottom:.0001pt;'><font face="Times New Roman,serif" lang=EN-US style='font-size:8.0pt;'>&nbsp;</font></p>
<p style='margin:0in;margin-bottom:.0001pt;'><font color=black face="Times New Roman,serif" lang=EN-US style='font-size:10.0pt;'>[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</font></p>
<p style='margin:0in;margin-bottom:.0001pt;'><font color=black face="Times New Roman,serif" lang=EN-US style='font-size:10.0pt;'>[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</font></p>
<p style='margin:0in;margin-bottom:.0001pt;'><font color=black face="Times New Roman,serif" lang=EN-US style='font-size:10.0pt;'>[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</font></p>
<p style='margin:0in;margin-bottom:.0001pt;'><font color=black face="Times New Roman,serif" lang=EN-US style='font-size:10.0pt;'>[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</font></p>
<p style='margin:0in;margin-bottom:.0001pt;'><font face="Times New Roman,serif" lang=EN-US style='font-size:8.0pt;'>&nbsp;</font></p>
<HR noshade align="center" width="100%" size=2>
<DIV STYLE="page-break-before: always"></div>
<a name="page_2"></a>
<p style='margin:0in;margin-bottom:.0001pt;'><b><font color=black face="Times New Roman,serif" lang=EN-US style='font-size:10.0pt;'>SECTION 1. Registrant's Business and Operations</font></b></p>
<p style='line-height:12.0pt;margin:0in;margin-bottom:.0001pt;'><font color=black face="Times New Roman,serif" lang=EN-US style='font-size:10.0pt;'>&nbsp;</font></p>
<p style='line-height:12.0pt;margin:0in;margin-bottom:.0001pt;'><font color=black face="Times New Roman,serif" lang=EN-US style='font-size:10.0pt;'>None.</font></p>
<p style='margin:0in;margin-bottom:.0001pt;'><font face="Times New Roman,serif" lang=EN-US style='font-size:8.0pt;'>&nbsp;</font></p>
<p style='margin:0in;margin-bottom:.0001pt;'><b><font color=black face="Times New Roman,serif" lang=EN-US style='font-size:10.0pt;'>SECTION 2. &nbsp;Financial Information</font></b></p>
<p style='margin:0in;margin-bottom:.0001pt;'><font face="Times New Roman,serif" lang=EN-US style='font-size:8.0pt;'>&nbsp;</font></p>
<p style='margin:0in;margin-bottom:.0001pt;text-align:justify;'><font color=black face="Times New Roman,serif" lang=EN-US style='font-size:10.0pt;'>None.</font></p>
<p style='margin:0in;margin-bottom:.0001pt;'><font face="Times New Roman,serif" lang=EN-US style='font-size:8.0pt;'>&nbsp;</font></p>
<p style='margin:0in;margin-bottom:.0001pt;'><b><font color=black face="Times New Roman,serif" lang=EN-US style='font-size:10.0pt;'>SECTION 3. &nbsp;Securities and Trading Markets</font></b></p>
<p style='margin:0in;margin-bottom:.0001pt;'><font face="Times New Roman,serif" lang=EN-US style='font-size:8.0pt;'>&nbsp;</font></p>
<p style='margin:0in;margin-bottom:.0001pt;'><font color=black face="Times New Roman,serif" lang=EN-US style='font-size:10.0pt;'>None.</font></p>
<p style='margin:0in;margin-bottom:.0001pt;'><font face="Times New Roman,serif" lang=EN-US style='font-size:8.0pt;'>&nbsp;</font></p>
<p style='margin:0in;margin-bottom:.0001pt;'><b><font color=black face="Times New Roman,serif" lang=EN-US style='font-size:10.0pt;'>SECTION 4. &nbsp;Matters Related to Accountants and Financial Statements</font></b></p>
<p style='margin:0in;margin-bottom:.0001pt;'><font face="Times New Roman,serif" lang=EN-US style='font-size:8.0pt;'>&nbsp;</font></p>
<p style='margin:0in;margin-bottom:.0001pt;text-align:justify;'><font color=black face="Times New Roman,serif" lang=EN-US style='font-size:10.0pt;'>None.</font></p>
<p style='margin:0in;margin-bottom:.0001pt;'><font face="Times New Roman,serif" lang=EN-US style='font-size:8.0pt;'>&nbsp;</font></p>
<p style='margin:0in;margin-bottom:.0001pt;'><b><font color=black face="Times New Roman,serif" lang=EN-US style='font-size:10.0pt;'>SECTION 5. &nbsp;Corporate Governance and Management</font></b></p>
<p style='margin:0in;margin-bottom:.0001pt;'><font face="Times New Roman,serif" lang=EN-US style='font-size:8.0pt;'>&nbsp;</font></p>
<p style='margin:0in;margin-bottom:.0001pt;text-align:justify;'><font color=black face="Times New Roman,serif" lang=EN-US style='font-size:10.0pt;'>None.</font></p>
<p style='margin:0in;margin-bottom:.0001pt;'><font face="Times New Roman,serif" lang=EN-US style='font-size:8.0pt;'>&nbsp;</font></p>
<p style='margin:0in;margin-bottom:.0001pt;text-align:justify;'><b><font color=black face="Times New Roman,serif" lang=EN-US style='font-size:10.0pt;'>SECTION 6. [Reserved]</font></b></p>
<p style='margin:0in;margin-bottom:.0001pt;'><font face="Times New Roman,serif" lang=EN-US style='font-size:2.0pt;'>&nbsp;</font></p>
<p style='margin:0in;margin-bottom:.0001pt;'><font face="Times New Roman,serif" lang=EN-US style='font-size:2.0pt;'>&nbsp;</font></p>
<p style='margin:0in;margin-bottom:.0001pt;'><font color=black face="Times New Roman,serif" lang=EN-US style='font-size:10.0pt;'>N/A.</font></p>
<p style='margin:0in;margin-bottom:.0001pt;'><font face="Times New Roman,serif" lang=EN-US style='font-size:8.0pt;'>&nbsp;</font></p>
<p style='margin:0in;margin-bottom:.0001pt;text-align:justify;'><b><font color=black face="Times New Roman,serif" lang=EN-US style='font-size:10.0pt;'>SECTION 7. &nbsp;Regulation FD</font></b></p>
<p style='margin:0in;margin-bottom:.0001pt;'><font face="Times New Roman,serif" lang=EN-US style='font-size:8.0pt;'>&nbsp;</font></p>
<p style='margin:0in;margin-bottom:.0001pt;text-align:justify;'><font color=black face="Times New Roman,serif" lang=EN-US style='font-size:10.0pt;'>Except for the historical information presented in this document, the matters discussed in this Form 8-K, or otherwise incorporated by reference into this document, contain &quot;forward-looking statements&quot; (as such term is defined in the Private Securities Litigation Reform Act of 1995). These statements are identified by the use of forward-looking terminology such as &quot;believes&quot;, &quot;plans&quot;, &quot;intend&quot;, &quot;scheduled&quot;, &quot;potential&quot;, &quot;continue&quot;, &quot;estimates&quot;, &quot;hopes&quot;, &quot;goal&quot;, &quot;objective&quot;, expects&quot;, &quot;may&quot;, &quot;will&quot;, &quot;should&quot; or &quot;anticipates&quot; or the negative thereof or other variations thereon or comparable terminology, or by discussions of strategy that involve risks and uncertainties. The safe harbor provisions of Section 21E of the Securities Exchange Act of 1934, as amended, and Section 27A of the Securities Act of 1933, as amended, apply to forward-looking statements made by the Registrant. The reader is cautioned that no statements contained in this Form 8-K should be construed as a guarantee or assurance of future performance or results. These forward-looking statements involve risks and uncertainties, including those identified within this Form 8-K. The actual results that the Registrant achieves may differ materially from any forward-looking statements due to such risks and uncertainties. These forward-looking statements are based on current expectations, and the Registrant assumes no obligation to update this information. Readers are urged to carefully review and consider the various disclosures made by the Registrant in this Form 8-K and in the Registrant's other reports filed with the Securities and Exchange Commission that attempt to advise interested parties of the risks and factors that may affect the Registrant's business.</font></p>
<p style='margin:0in;margin-bottom:.0001pt;'><font face="Times New Roman,serif" lang=EN-US style='font-size:8.0pt;'>&nbsp;</font></p>
<p style='margin:0in;margin-bottom:.0001pt;text-align:justify;'><font color=black face="Times New Roman,serif" lang=EN-US style='font-size:10.0pt;'>Note: Information in this report furnished pursuant to Item 7 shall not be deemed to be &quot;filed&quot; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section. The information in this current report shall not be incorporated by reference into any registration statement pursuant to the Securities Act of 1933, as amended. The furnishing of the information in this current report is not intended to, and does not, constitute a representation that such furnishing is required by Regulation FD or that the information this current report contains is material investor information that is not otherwise publicly available.</font></p>
<p style='margin:0in;margin-bottom:.0001pt;'><font face="Times New Roman,serif" lang=EN-US style='font-size:8.0pt;'>&nbsp;</font></p>
<p style='margin:0in;margin-bottom:.0001pt;text-align:justify;'><font color=black face="Times New Roman,serif" lang=EN-US style='font-size:10.0pt;'>On August 5, 2009, PhytoMedical Technologies, Inc. issued a news release to announce</font><font face="Times New Roman,serif" lang=EN-US style='font-size:10.0pt;'> their partnership with Latitude Pharmaceuticals, Inc. to develop an IV Formulation for its lead anti cancer compound for glioblastoma.</font></p>
<p style='margin:0in;margin-bottom:.0001pt;text-align:justify;'><font face="Times New Roman,serif" lang=EN-US style='font-size:10.0pt;'>&nbsp;</font></p>
<p style='margin:0in;margin-bottom:.0001pt;text-align:justify;'><font color=black face="Times New Roman,serif" lang=EN-US style='font-size:10.0pt;'>This news release, dated August 5, 2009 is attached as Exhibit 99.1 to this Form 8-K.</font></p>
<p style='margin:0in;margin-bottom:.0001pt;text-align:justify;'><font color=black face="Times New Roman,serif" lang=EN-US style='font-size:10.0pt;'>&nbsp;</font></p>
<p style='margin:0in;margin-bottom:.0001pt;text-align:justify;'><font face="Times New Roman,serif" lang=EN-US style='font-size:10.0pt;'>&nbsp;</font></p>
<p style='margin:0in;margin-bottom:.0001pt;'><font face="Times New Roman,serif" lang=EN-US style='font-size:8.0pt;'>&nbsp;</font></p>
<p style='margin:0in;margin-bottom:.0001pt;text-align:justify;'><b><font color=black face="Times New Roman,serif" lang=EN-US style='font-size:10.0pt;'>SECTION 8. &nbsp;Other Events</font></b></p>
<p style='margin:0in;margin-bottom:.0001pt;'><font face="Times New Roman,serif" lang=EN-US style='font-size:8.0pt;'>&nbsp;</font></p>
<HR noshade align="center" width="100%" size=2>
<DIV STYLE="page-break-before: always"></div>
<a name="page_3"></a>
<p style='margin:0in;margin-bottom:.0001pt;text-align:justify;'><font color=black face="Times New Roman,serif" lang=EN-US style='font-size:10.0pt;'>Item 8.01 Other Events.</font></p>
<p style='margin:0in;margin-bottom:.0001pt;'><font color=black face="Times New Roman,serif" lang=EN-US style='font-size:10.0pt;'>&#160;</font></p>
<p style='margin:0in;margin-bottom:.0001pt;text-align:justify;'><b><font color=black face="Times New Roman,serif" lang=EN-US style='font-size:10.0pt;'>SECTION 9. &nbsp;Financial Statements and Exhibits
<a name="part_1_2_1"></a>
<a name="item_1_47_1"></a></font></b></p>
<p style='margin:0in;margin-bottom:.0001pt;'><font face="Times New Roman,serif" lang=EN-US style='font-size:8.0pt;'>&nbsp;</font></p>
<p style='margin:0in;margin-bottom:.0001pt;text-align:justify;'>
<a name="part_1_2_2"></a><u><font color=black face="Times New Roman,serif" lang=EN-US style='font-size:10.0pt;'>Item 9.01 &nbsp;Financial Statements and Exhibits</font></u></p>
<p style='margin:0in;margin-bottom:.0001pt;'><font face="Times New Roman,serif" lang=EN-US style='font-size:8.0pt;'>&nbsp;</font></p>
<p style='margin:0in;margin-bottom:.0001pt;text-align:justify;'><font color=black face="Times New Roman,serif" lang=EN-US style='font-size:10.0pt;'>The following exhibit is furnished as part of this report:</font></p>
<p style='margin:0in;margin-bottom:.0001pt;'><font face="Times New Roman,serif" lang=EN-US style='font-size:8.0pt;'>&nbsp;</font></p>
<p style='margin:0in;margin-bottom:.0001pt;text-align:justify;'><font color=black face="Times New Roman,serif" lang=EN-US style='font-size:10.0pt;'>Exhibit 99.1 &#8211; Press release dated August 5, 2009.</font></p>
<p style='margin:0in;margin-bottom:.0001pt;'><font face="Times New Roman,serif" lang=EN-US style='font-size:8.0pt;'>&nbsp;</font></p>
<p style='margin:0in;margin-bottom:.0001pt;margin-left:2.0in;text-indent:.5in;'><b><font color=black face="Times New Roman,serif" lang=EN-US style='font-size:10.0pt;'>&#160;&#160; </font></b></p>
<p style='margin:0in;margin-bottom:.0001pt;margin-left:2.0in;text-indent:.5in;'><b><font color=black face="Times New Roman,serif" lang=EN-US style='font-size:10.0pt;'>&nbsp;</font></b></p>
<p style='margin:0in;margin-bottom:.0001pt;margin-left:2.0in;text-indent:.5in;'><b><font color=black face="Times New Roman,serif" lang=EN-US style='font-size:10.0pt;'>&nbsp;</font></b></p>
<p style='margin:0in;margin-bottom:.0001pt;margin-left:2.0in;text-indent:.5in;'><b><font color=black face="Times New Roman,serif" lang=EN-US style='font-size:10.0pt;'>&nbsp;</font></b></p>
<p style='margin:0in;margin-bottom:.0001pt;margin-left:2.0in;text-indent:.5in;'><b><font color=black face="Times New Roman,serif" lang=EN-US style='font-size:10.0pt;'>&nbsp;</font></b></p>
<p style='margin:0in;margin-bottom:.0001pt;margin-left:2.0in;text-indent:.5in;'><b><font color=black face="Times New Roman,serif" lang=EN-US style='font-size:10.0pt;'>&nbsp;</font></b></p>
<p align=center style='margin:0in;margin-bottom:.0001pt;text-align:center;'><b><font color=black face="Times New Roman,serif" lang=EN-US style='font-size:10.0pt;'>&nbsp;</font></b></p>
<p align=center style='margin:0in;margin-bottom:.0001pt;text-align:center;'><b><font color=black face="Times New Roman,serif" lang=EN-US style='font-size:10.0pt;'>&nbsp;</font></b></p>
<p align=center style='margin:0in;margin-bottom:.0001pt;text-align:center;'><b><font color=black face="Times New Roman,serif" lang=EN-US style='font-size:10.0pt;'>&nbsp;</font></b></p>
<p align=center style='margin:0in;margin-bottom:.0001pt;text-align:center;'><b><font color=black face="Times New Roman,serif" lang=EN-US style='font-size:10.0pt;'>&nbsp;</font></b></p>
<p align=center style='margin:0in;margin-bottom:.0001pt;text-align:center;'><b><font color=black face="Times New Roman,serif" lang=EN-US style='font-size:10.0pt;'>&nbsp;</font></b></p>
<p align=center style='margin:0in;margin-bottom:.0001pt;text-align:center;'><b><font color=black face="Times New Roman,serif" lang=EN-US style='font-size:10.0pt;'>&nbsp;</font></b></p>
<p align=center style='margin:0in;margin-bottom:.0001pt;text-align:center;'><b><font color=black face="Times New Roman,serif" lang=EN-US style='font-size:10.0pt;'>&nbsp;</font></b></p>
<p align=center style='margin:0in;margin-bottom:.0001pt;text-align:center;'><b><font color=black face="Times New Roman,serif" lang=EN-US style='font-size:10.0pt;'>&nbsp;</font></b></p>
<p align=center style='margin:0in;margin-bottom:.0001pt;text-align:center;'><b><font color=black face="Times New Roman,serif" lang=EN-US style='font-size:10.0pt;'>&nbsp;</font></b></p>
<p align=center style='margin:0in;margin-bottom:.0001pt;text-align:center;'><b><font color=black face="Times New Roman,serif" lang=EN-US style='font-size:10.0pt;'>&nbsp;</font></b></p>
<p align=center style='margin:0in;margin-bottom:.0001pt;text-align:center;'><b><font color=black face="Times New Roman,serif" lang=EN-US style='font-size:10.0pt;'>&nbsp;</font></b></p>
<p align=center style='margin:0in;margin-bottom:.0001pt;text-align:center;'><b><font color=black face="Times New Roman,serif" lang=EN-US style='font-size:10.0pt;'>&nbsp;</font></b></p>
<p align=center style='margin:0in;margin-bottom:.0001pt;text-align:center;'><b><font color=black face="Times New Roman,serif" lang=EN-US style='font-size:10.0pt;'>&nbsp;</font></b></p>
<p align=center style='margin:0in;margin-bottom:.0001pt;text-align:center;'><b><font color=black face="Times New Roman,serif" lang=EN-US style='font-size:10.0pt;'>&nbsp;</font></b></p>
<p align=center style='margin:0in;margin-bottom:.0001pt;text-align:center;'><b><font color=black face="Times New Roman,serif" lang=EN-US style='font-size:10.0pt;'>&nbsp;</font></b></p>
<p align=center style='margin:0in;margin-bottom:.0001pt;text-align:center;'><b><font color=black face="Times New Roman,serif" lang=EN-US style='font-size:10.0pt;'>&nbsp;</font></b></p>
<p align=center style='margin:0in;margin-bottom:.0001pt;text-align:center;'><b><font color=black face="Times New Roman,serif" lang=EN-US style='font-size:10.0pt;'>&nbsp;</font></b></p>
<p align=center style='margin:0in;margin-bottom:.0001pt;text-align:center;'><b><font color=black face="Times New Roman,serif" lang=EN-US style='font-size:10.0pt;'>&nbsp;</font></b></p>
<p align=center style='margin:0in;margin-bottom:.0001pt;text-align:center;'><b><font color=black face="Times New Roman,serif" lang=EN-US style='font-size:10.0pt;'>&nbsp;</font></b></p>
<p align=center style='margin:0in;margin-bottom:.0001pt;text-align:center;'><b><font color=black face="Times New Roman,serif" lang=EN-US style='font-size:10.0pt;'>&nbsp;</font></b></p>
<p align=center style='margin:0in;margin-bottom:.0001pt;text-align:center;'><b><font color=black face="Times New Roman,serif" lang=EN-US style='font-size:10.0pt;'>&nbsp;</font></b></p>
<p align=center style='margin:0in;margin-bottom:.0001pt;text-align:center;'><b><font color=black face="Times New Roman,serif" lang=EN-US style='font-size:10.0pt;'>&nbsp;</font></b></p>
<p align=center style='margin:0in;margin-bottom:.0001pt;text-align:center;'><b><font color=black face="Times New Roman,serif" lang=EN-US style='font-size:10.0pt;'>&nbsp;</font></b></p>
<p align=center style='margin:0in;margin-bottom:.0001pt;text-align:center;'><b><font color=black face="Times New Roman,serif" lang=EN-US style='font-size:10.0pt;'>&nbsp;</font></b></p>
<p align=center style='margin:0in;margin-bottom:.0001pt;text-align:center;'><b><font color=black face="Times New Roman,serif" lang=EN-US style='font-size:10.0pt;'>&nbsp;</font></b></p>
<p align=center style='margin:0in;margin-bottom:.0001pt;text-align:center;'><b><font color=black face="Times New Roman,serif" lang=EN-US style='font-size:10.0pt;'>&nbsp;</font></b></p>
<p align=center style='margin:0in;margin-bottom:.0001pt;text-align:center;'><b><font color=black face="Times New Roman,serif" lang=EN-US style='font-size:10.0pt;'>&nbsp;</font></b></p>
<p align=center style='margin:0in;margin-bottom:.0001pt;text-align:center;'><b><font color=black face="Times New Roman,serif" lang=EN-US style='font-size:10.0pt;'>&nbsp;</font></b></p>
<p align=center style='margin:0in;margin-bottom:.0001pt;text-align:center;'><b><font color=black face="Times New Roman,serif" lang=EN-US style='font-size:10.0pt;'>&nbsp;</font></b></p>
<p align=center style='margin:0in;margin-bottom:.0001pt;text-align:center;'><b><font color=black face="Times New Roman,serif" lang=EN-US style='font-size:10.0pt;'>&nbsp;</font></b></p>
<p align=center style='margin:0in;margin-bottom:.0001pt;text-align:center;'><b><font color=black face="Times New Roman,serif" lang=EN-US style='font-size:10.0pt;'>&nbsp;</font></b></p>
<p align=center style='margin:0in;margin-bottom:.0001pt;text-align:center;'><b><font color=black face="Times New Roman,serif" lang=EN-US style='font-size:10.0pt;'>&nbsp;</font></b></p>
<p align=center style='margin:0in;margin-bottom:.0001pt;text-align:center;'><b><font color=black face="Times New Roman,serif" lang=EN-US style='font-size:10.0pt;'>&nbsp;</font></b></p>
<p align=center style='margin:0in;margin-bottom:.0001pt;text-align:center;'><b><font color=black face="Times New Roman,serif" lang=EN-US style='font-size:10.0pt;'>&nbsp;</font></b></p>
<p align=center style='margin:0in;margin-bottom:.0001pt;text-align:center;'><b><font color=black face="Times New Roman,serif" lang=EN-US style='font-size:10.0pt;'>&nbsp;</font></b></p>
<p align=center style='margin:0in;margin-bottom:.0001pt;text-align:center;'><b><font color=black face="Times New Roman,serif" lang=EN-US style='font-size:10.0pt;'>&nbsp;</font></b></p>
<p align=center style='margin:0in;margin-bottom:.0001pt;text-align:center;'><b><font color=black face="Times New Roman,serif" lang=EN-US style='font-size:10.0pt;'>&nbsp;</font></b></p>
<p align=center style='margin:0in;margin-bottom:.0001pt;text-align:center;'><b><font color=black face="Times New Roman,serif" lang=EN-US style='font-size:10.0pt;'>&nbsp;</font></b></p>
<p align=center style='margin:0in;margin-bottom:.0001pt;text-align:center;'><b><font color=black face="Times New Roman,serif" lang=EN-US style='font-size:10.0pt;'>&nbsp;</font></b></p>
<p align=center style='margin:0in;margin-bottom:.0001pt;text-align:center;'><b><font color=black face="Times New Roman,serif" lang=EN-US style='font-size:10.0pt;'>&nbsp;</font></b></p>
<p align=center style='margin:0in;margin-bottom:.0001pt;text-align:center;'><b><font color=black face="Times New Roman,serif" lang=EN-US style='font-size:10.0pt;'>&nbsp;</font></b></p>
<HR noshade align="center" width="100%" size=2>
<DIV STYLE="page-break-before: always"></div>
<A name="page_4"></A>
<P style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt" align=center><B><FONT style="FONT-SIZE: 10pt" lang=EN-US color=black face="Times New Roman,serif">SIGNATURES</FONT></B></P>
<P style="MARGIN: 0in 0in 0pt"><FONT style="FONT-SIZE: 8pt" lang=EN-US face="Times New Roman,serif"></FONT>&nbsp;</P>
<P style="TEXT-ALIGN: justify; MARGIN: 0in 0in 0pt"><FONT style="FONT-SIZE: 10pt" lang=EN-US color=black face="Times New Roman,serif">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</FONT></P>
<P style="MARGIN: 0in 0in 0pt"><FONT style="FONT-SIZE: 8pt" lang=EN-US face="Times New Roman,serif"></FONT>&nbsp;</P>
<P style="TEXT-INDENT: 178.2pt; MARGIN: 0in 0in 0pt"><B><FONT style="FONT-SIZE: 10pt" lang=EN-US color=black face="Times New Roman,serif"></FONT></B>&nbsp;</P>
<P style="TEXT-INDENT: 178.2pt; MARGIN: 0in 0in 0pt"><B><FONT style="FONT-SIZE: 10pt" lang=EN-US color=black face="Times New Roman,serif"></FONT></B>&nbsp;</P>
<P style="LINE-HEIGHT: 12pt; TEXT-INDENT: 3in; MARGIN: 0in 0in 0pt"><B><FONT style="FONT-SIZE: 10pt" lang=EN-US color=black face="Times New Roman,serif">PHYTOMEDICAL TECHNOLOGIES, INC.</FONT></B></P>
<P style="LINE-HEIGHT: 12pt; MARGIN: 0in 0in 0pt"><FONT style="FONT-SIZE: 10pt" lang=EN-US color=black face="Times New Roman,serif"></FONT>&nbsp;</P>
<P style="TEXT-ALIGN: left; LINE-HEIGHT: 12pt; MARGIN: 0in 0in 0pt" align=center><FONT style="FONT-SIZE: 10pt" lang=EN-US color=black face="Times New Roman,serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><U><FONT style="FONT-SIZE: 10pt" lang=EN-US color=black face="Times New Roman,serif">/s/Greg Wujek</FONT></U></P>
<P style="LINE-HEIGHT: 12pt; TEXT-INDENT: 3in; MARGIN: 0in 0in 0pt"><FONT style="FONT-SIZE: 10pt" lang=EN-US color=black face="Times New Roman,serif">Greg Wujek</FONT></P>
<P style="LINE-HEIGHT: 12pt; TEXT-INDENT: 3in; MARGIN: 0in 0in 0pt"><FONT style="FONT-SIZE: 10pt" lang=EN-US color=black face="Times New Roman,serif">President and CEO</FONT></P>
<P style="LINE-HEIGHT: 12pt; TEXT-INDENT: -1in; MARGIN: 0in 0in 0pt"><FONT style="FONT-SIZE: 10pt" lang=EN-US color=black face="Times New Roman,serif"></FONT>&nbsp;</P>
<P style="TEXT-ALIGN: justify; TEXT-INDENT: -59.4pt; MARGIN: 0in 0in 0pt 3.3in"><FONT style="FONT-SIZE: 10pt" lang=EN-US color=black face="Times New Roman,serif"></FONT>&nbsp;</P>
<P style="TEXT-ALIGN: justify; MARGIN: 0in 0in 0pt"><FONT style="FONT-SIZE: 10pt" lang=EN-US color=black face="Times New Roman,serif">Date: August 5, 2009</FONT></P>
<P style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt" align=center><FONT style="FONT-SIZE: 10pt" lang=EN-US face="Times New Roman,serif"></FONT>&nbsp;</P>
<P style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt" align=center><FONT style="FONT-SIZE: 10pt" lang=EN-US face="Times New Roman,serif"></FONT>&nbsp;</P>
<P style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt" align=center><FONT style="FONT-SIZE: 10pt" lang=EN-US face="Times New Roman,serif"></FONT>&nbsp;</P>
<P style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt" align=center><FONT style="FONT-SIZE: 10pt" lang=EN-US face="Times New Roman,serif"></FONT>&nbsp;</P>
<P style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt" align=center><FONT style="FONT-SIZE: 10pt" lang=EN-US face="Times New Roman,serif"></FONT>&nbsp;</P>
<P style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt" align=center><FONT style="FONT-SIZE: 10pt" lang=EN-US face="Times New Roman,serif"></FONT>&nbsp;</P>
<P style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt" align=center><FONT style="FONT-SIZE: 10pt" lang=EN-US face="Times New Roman,serif"></FONT>&nbsp;</P>
<P style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt" align=center><FONT style="FONT-SIZE: 10pt" lang=EN-US face="Times New Roman,serif"></FONT>&nbsp;</P>
<P style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt" align=center><FONT style="FONT-SIZE: 10pt" lang=EN-US face="Times New Roman,serif"></FONT>&nbsp;</P>
<P style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt" align=center><FONT style="FONT-SIZE: 10pt" lang=EN-US face="Times New Roman,serif"></FONT>&nbsp;</P>
<P style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt" align=center><FONT style="FONT-SIZE: 10pt" lang=EN-US face="Times New Roman,serif"></FONT>&nbsp;</P>
<P style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt" align=center><FONT style="FONT-SIZE: 10pt" lang=EN-US face="Times New Roman,serif"></FONT>&nbsp;</P>
<P style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt" align=center><FONT style="FONT-SIZE: 10pt" lang=EN-US face="Times New Roman,serif"></FONT>&nbsp;</P>
<P style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt" align=center><FONT style="FONT-SIZE: 10pt" lang=EN-US face="Times New Roman,serif"></FONT>&nbsp;</P>
<P style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt" align=center><FONT style="FONT-SIZE: 10pt" lang=EN-US face="Times New Roman,serif"></FONT>&nbsp;</P>
<P style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt" align=center><FONT style="FONT-SIZE: 10pt" lang=EN-US face="Times New Roman,serif"></FONT>&nbsp;</P>
<P style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt" align=center><FONT style="FONT-SIZE: 10pt" lang=EN-US face="Times New Roman,serif"></FONT>&nbsp;</P>
<P style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt" align=center><FONT style="FONT-SIZE: 10pt" lang=EN-US face="Times New Roman,serif"></FONT>&nbsp;</P>
<P style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt" align=center><FONT style="FONT-SIZE: 10pt" lang=EN-US face="Times New Roman,serif"></FONT>&nbsp;</P>
<P style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt" align=center><FONT style="FONT-SIZE: 10pt" lang=EN-US face="Times New Roman,serif"></FONT>&nbsp;</P>
<P style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt" align=center><FONT style="FONT-SIZE: 10pt" lang=EN-US face="Times New Roman,serif"></FONT>&nbsp;</P>
<P style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt" align=center><FONT style="FONT-SIZE: 10pt" lang=EN-US face="Times New Roman,serif"></FONT>&nbsp;</P>
<P style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt" align=center><FONT style="FONT-SIZE: 10pt" lang=EN-US face="Times New Roman,serif"></FONT>&nbsp;</P>
<P style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt" align=center><FONT style="FONT-SIZE: 10pt" lang=EN-US face="Times New Roman,serif"></FONT>&nbsp;</P>
<P style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt" align=center><FONT style="FONT-SIZE: 10pt" lang=EN-US face="Times New Roman,serif"></FONT>&nbsp;</P>
<P style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt" align=center><FONT style="FONT-SIZE: 10pt" lang=EN-US face="Times New Roman,serif"></FONT>&nbsp;</P>
<P style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt" align=center><FONT style="FONT-SIZE: 10pt" lang=EN-US face="Times New Roman,serif"></FONT>&nbsp;</P>
<P style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt" align=center><FONT style="FONT-SIZE: 10pt" lang=EN-US face="Times New Roman,serif"></FONT>&nbsp;</P>
<P style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt" align=center><FONT style="FONT-SIZE: 10pt" lang=EN-US face="Times New Roman,serif"></FONT>&nbsp;</P>
<P style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt" align=center><FONT style="FONT-SIZE: 10pt" lang=EN-US face="Times New Roman,serif"></FONT>&nbsp;</P>
<P style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt" align=center><FONT style="FONT-SIZE: 10pt" lang=EN-US face="Times New Roman,serif"></FONT>&nbsp;</P>
<P style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt" align=center><FONT style="FONT-SIZE: 10pt" lang=EN-US face="Times New Roman,serif"></FONT>&nbsp;</P>
<P style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt" align=center><FONT style="FONT-SIZE: 10pt" lang=EN-US face="Times New Roman,serif"></FONT>&nbsp;</P>
<P style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt" align=center><FONT style="FONT-SIZE: 10pt" lang=EN-US face="Times New Roman,serif"></FONT>&nbsp;</P>
<P style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt" align=center><FONT style="FONT-SIZE: 10pt" lang=EN-US face="Times New Roman,serif"></FONT>&nbsp;</P>
<P style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt" align=center><FONT style="FONT-SIZE: 10pt" lang=EN-US face="Times New Roman,serif"></FONT>&nbsp;</P>
<HR align=center SIZE=2 width="100%" noShade>
<DIV style="PAGE-BREAK-BEFORE: always"></DIV>
</BODY>

</HTML>
[{"type": "8-K", "sequence": "1", "filename": "phytomedical8k.htm", "secsgml_size_bytes": 36103}]
{"company-data": {"conformed-name": "PHYTOMEDICAL TECHNOLOGIES INC", "cik": "0001002422", "assigned-sic": "8093", "irs-number": "870429962", "state-of-incorporation": "NV", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-28790", "film-number": "091001431"}, "business-address": {"street1": "100 OVERLOOK DRIVE", "street2": "2ND FLOOR", "city": "PRINCETON", "state": "NJ", "zip": "08540", "phone": "604-659-5004"}, "mail-address": {"street1": "100 OVERLOOK DRIVE", "street2": "2ND FLOOR", "city": "PRINCETON", "state": "NJ", "zip": "08540"}, "former-company": [{"former-conformed-name": "ENTERPRISE TECHNOLOGIES INC", "date-changed": "20021220"}, {"former-conformed-name": "MEDCARE TECHNOLOGIES INC", "date-changed": "19960917"}]}
phytomedical8k.htm - Generated by SEC Publisher for SEC Filing
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.  20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
August 5, 2009
Date of Report (Date of earliest event reported)
PhytoMedical Technologies, Inc.
(Exact name of registrant as specified in its charter)
Nevada
(State or other jurisdiction of incorporation)
000-28790
(Commission File Number)
87-0429962
(I.R.S. Employer Identification No.)
100 Overlook Drive, 2nd Floor, Princeton, NJ  08540
(Address of principal executive offices)
(800) 611-3388
(Registrant's telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
SECTION 1. Registrant's Business and Operations
None.
SECTION 2.  Financial Information
None.
SECTION 3.  Securities and Trading Markets
None.
SECTION 4.  Matters Related to Accountants and Financial Statements
None.
SECTION 5.  Corporate Governance and Management
None.
SECTION 6. [Reserved]
N/A.
SECTION 7.  Regulation FD
Except for the historical information presented in this document, the matters discussed in this Form 8-K, or otherwise incorporated by reference into this document, contain "forward-looking statements" (as such term is defined in the Private Securities Litigation Reform Act of 1995). These statements are identified by the use of forward-looking terminology such as "believes", "plans", "intend", "scheduled", "potential", "continue", "estimates", "hopes", "goal", "objective", expects", "may", "will", "should" or "anticipates" or the negative thereof or other variations thereon or comparable terminology, or by discussions of strategy that involve risks and uncertainties. The safe harbor provisions of Section 21E of the Securities Exchange Act of 1934, as amended, and Section 27A of the Securities Act of 1933, as amended, apply to forward-looking statements made by the Registrant. The reader is cautioned that no statements contained in this Form 8-K should be construed as a guarantee or assurance of future performance or results. These forward-looking statements involve risks and uncertainties, including those identified within this Form 8-K. The actual results that the Registrant achieves may differ materially from any forward-looking statements due to such risks and uncertainties. These forward-looking statements are based on current expectations, and the Registrant assumes no obligation to update this information. Readers are urged to carefully review and consider the various disclosures made by the Registrant in this Form 8-K and in the Registrant's other reports filed with the Securities and Exchange Commission that attempt to advise interested parties of the risks and factors that may affect the Registrant's business.
Note: Information in this report furnished pursuant to Item 7 shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section. The information in this current report shall not be incorporated by reference into any registration statement pursuant to the Securities Act of 1933, as amended. The furnishing of the information in this current report is not intended to, and does not, constitute a representation that such furnishing is required by Regulation FD or that the information this current report contains is material investor information that is not otherwise publicly available.
On August 5, 2009, PhytoMedical Technologies, Inc. issued a news release to announce
their partnership with Latitude Pharmaceuticals, Inc. to develop an IV Formulation for its lead anti cancer compound for glioblastoma.
This news release, dated August 5, 2009 is attached as Exhibit 99.1 to this Form 8-K.
SECTION 8.  Other Events
Item 8.01 Other Events.
SECTION 9.  Financial Statements and Exhibits
Item 9.01  Financial Statements and Exhibits
The following exhibit is furnished as part of this report:
Exhibit 99.1 – Press release dated August 5, 2009.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
PHYTOMEDICAL TECHNOLOGIES, INC.
/s/Greg Wujek
Greg Wujek
President and CEO
Date: August 5, 2009